Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Follicle Stimulating Hormone Global Market Report 2025
Download Free Sample Buy Now
Global Follicle Stimulating Hormone Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Follicle Stimulating Hormone Global Market Report 2025

By Type (Recombinant FSH, Urinary FSH), By Application (Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications), By End-Users (Infertility Center, Hospitals, Other End-Users ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Follicle Stimulating Hormone Market Overview

• Follicle Stimulating Hormone market size has reached to $2.03 billion in 2024

• Expected to grow to $2.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%

• Growth Driver: The Role Of Follicle-Stimulating Hormone In Addressing The Growing Prevalence Of Infertility

• Market Trend: Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Follicle Stimulating Hormone Market?

Follicle-stimulating hormone is a hormone that the pituitary gland secretes and is involved in sexual maturation and reproduction. It has an impact on how well the testicles and ovaries work. Follicle-stimulating hormone assists in regulating both the ovaries' egg production and the menstrual cycle.

The main types of follicles stimulating hormones are recombinant FSH and urinary FSH. Recombinant FSH (Follicle-Stimulating Hormone) is a type of FSH that is synthesized using recombinant DNA technology instead of being sourced from natural sources like urine. These are used for several applications, including infertility treatment, assisted reproductive technology (ART), and others, which are used by various end-users, such as infertility centers, hospitals, and others.

Follicle Stimulating Hormone Market Size and growth rate 2025 to 2029: Graph

What Is The Follicle Stimulating Hormone Market Size 2025 And Growth Rate?

The follicle stimulating hormone market size has grown strongly in recent years. It will grow from $2.03 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to increased prevalence of hormonal disorders, growing demand for fertility treatment, expansion of FSH indications, market entry of new FSH products, growing demand for safe and effective contraceptive options

What Is The Follicle Stimulating Hormone Market Growth Forecast?

The follicle stimulating hormone market size is expected to see strong growth in the next few years. It will grow to $2.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to widening therapeutic applications, rising demand for combination therapy, growing need for effective contraceptive options, aging population and related healthcare needs, market expansion in key regions. Major trends in the forecast period include advanced biosimilar FSH products, regulatory approvals and market access, technological advancements in FSH production and delivery, growing need for effective contraceptive options.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations could challenge U.S. fertility treatments by driving up the cost of recombinant follicle-stimulating hormone injections and ovarian monitoring ultrasound equipment sourced from the Netherlands and Israel, increasing assisted reproduction costs and reducing in vitro fertilization success rates. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Follicle Stimulating Hormone Market Segmented?

1) By Type: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

Subsegments:

1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations

2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones

What Is Driving The Follicle Stimulating Hormone Market? The Role Of Follicle-Stimulating Hormone In Addressing The Growing Prevalence Of Infertility

The increasing prevalence of infertility is expected to propel the growth of the follicle-stimulating hormone market. Infertility is a condition affecting the male or female reproductive system that is indicated by the inability to conceive after 12 months or longer of frequent, unprotected sexual contact. Follicle-stimulating hormone encourages the development of eggs in the ovaries and aids in regulating the menstrual cycle in females. It promotes testicular growth in men and aids in producing a protein essential for male fertility by promoting the development of healthy sperm cells. For instance, in April 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, infertility affected around 1 in 6 adults worldwide, or about 17.5% of the adult population. Furthermore, in October 2023, according to the Australian Bureau of Statistics, an Australia-based self-governing constitutional organization entrusted with gathering and analyzing information and making fact-based recommendations to the national, state, and territory governments, there were 300,684 recorded births in 2022, a 3% drop from 2021. The overall fertility rate for all Australian women was 1.63 births per woman. Therefore, the increasing prevalence of infertility is driving the growth of the follicle-stimulating hormone market.

What Is Driving The Follicle Stimulating Hormone Market? Follicle-Stimulating Hormone Market Surges With The Rising Adoption Of Assisted Reproductive Technology

The increasing adoption of assisted reproductive technology is expected to propel the growth of the follicle-stimulating hormone market in the coming years. Assisted Reproductive Technology (ART) is a term for medical procedures or practices that help people or couples conceive when traditional means have failed. The use of follicle-stimulating hormone in assisted reproductive technology is a well-established therapy that tries to improve the odds of a successful pregnancy for people or couples who are experiencing reproductive issues. For instance, in March 2024, according to the US department of Health and Human services, a US-based government agency, the use of assisted reproductive technology (ART) increases with maternal age. In 2023, 9% of live births among women aged 40-45 involved ART, rising to nearly one-third for women 45 and older. ART usage also varies by region in the U.S. Therefore, the increasing adoption of assisted reproductive technology is driving the follicle-stimulating hormone market.

Who Are The Major Players In The Global Follicle Stimulating Hormone Market?

Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.

What Are The Key Trends Of The Global Follicle Stimulating Hormone Market? Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility Treatment

Product innovations are a key trend gaining popularity in the follicle-stimulating hormone market. Major companies operating in the follicle-stimulating hormone market are focused on developing innovative products to strengthen their position in the market. For instance, in July 2024, Proov, a US-based women's health company, launched the Proov Empower Perimenopause Testing System. Proov Empower offers comprehensive and personalized insights into how a woman’s changing hormones affect her overall health and wellness. This non-invasive, multi-time point urine test measures four key hormones—FSH, estrogen marker E1G, progesterone marker PdG, and LH—that influence symptoms and the perimenopause experience. By providing periodic retesting, Proov Empower helps women track hormone fluctuations and symptoms, serving as a valuable guide during the transition to menopause.

What Are The Key Trends Of The Global Follicle Stimulating Hormone Market? Innovative Advancements In The Follicle-Stimulating Hormone Market

Major companies operating in the follicle-stimulating hormone market are developing innovative products such as estrogen-based pills to enhance product offerings and gain a competitive advantage. Estrogen-based pills are drugs containing estrogen, a hormone that is essential in the growth and management of the female reproductive system. For instance, in August 2022, Myovant Sciences Ltd., a UK-based biopharmaceutical company, and Pfizer Inc., a US-based pharmaceutical and biotechnology firm, announced that MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) had been authorized by the US Food and Drug Administration (FDA) as a one-pill treatment. MYFEMBREE is a once-daily medicine used to treat moderate to severe pain caused by endometriosis in premenopausal women for up to 24 months. The authorization is based on one-year effectiveness and safety data, including 24-week data from the Lancet-published Phase 3 SPIRIT 1 and SPIRIT 2 studies, as well as the first 28 weeks of an open-label extension study for eligible women who finished either SPIRIT 1 or SPIRIT 2. MYFEMBREE is also authorized for premenopausal women for excessive menstrual bleeding caused by uterine fibroids. Myovant and Pfizer intend to keep jointly marketing MYFEMBREE in the United States.

Need data on a specific region in this market?
Request Regional Data

Follicle Stimulating Hormone Market Merger And Acquisition: Organon China Partners With Shanghai Bao Pharmaceutical To Accelerate Innovation In Assisted Reproductive Technology

In September 2024, Organon China, a China-based healthcare company, partnered with Shanghai Bao Pharmaceutical for SJ02, a Long-Acting FSH in the BLA Process, an Innovative Investigational Asset in Assisted Reproductive Technology (ART) in China Mainland. As a result of this partnership, Organon is advancing its 'In China, for China' strategy and expanding its fertility portfolio. By collaborating with China’s leading innovators, Organon aims to accelerate progress in assisted reproductive technology (ART) and provide additional fertility options to millions of Chinese families. Shanghai Bao Pharmaceutical is a China-based provider of follicle-stimulating hormone (FSH).

Regional Outlook For The Global Follicle Stimulating Hormone Market

North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Follicle Stimulating Hormone Market?

The follicle-stimulating hormone market consists of sales of luteinizing hormone (LH), chorionic gonadotropin (CG), and thyroid-stimulating hormone. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Follicle Stimulating Hormone Industry?

The follicle stimulating hormone market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the follicle stimulating hormone industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Follicle Stimulating Hormone Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.12 billion
Revenue Forecast In 2034 $2.59 billion
Growth Rate CAGR of 5.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Recombinant FSH, Urinary FSH
2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications
3) By End-Users: Infertility Center, Hospitals, Other End-Users Subsegments: 1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations
2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Follicle Stimulating Hormone Market Characteristics

3. Follicle Stimulating Hormone Market Trends And Strategies

4. Follicle Stimulating Hormone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Follicle Stimulating Hormone Growth Analysis And Strategic Analysis Framework

5.1. Global Follicle Stimulating Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Follicle Stimulating Hormone Market Growth Rate Analysis

5.4. Global Follicle Stimulating Hormone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Follicle Stimulating Hormone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Follicle Stimulating Hormone Total Addressable Market (TAM)

6. Follicle Stimulating Hormone Market Segmentation

6.1. Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant FSH

Urinary FSH

6.2. Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infertility Treatment

Assisted Reproductive Technology (ART)

Other Applications

6.3. Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infertility Center

Hospitals

Other End-Users

6.4. Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Recombinant FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pure Recombinant FSH

Mixed Recombinant FSH Formulations

6.5. Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Urinary FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Purified Urinary FSH

Urinary FSH Combined With Other Hormones

7. Follicle Stimulating Hormone Market Regional And Country Analysis

7.1. Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Follicle Stimulating Hormone Market

8.1. Asia-Pacific Follicle Stimulating Hormone Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Follicle Stimulating Hormone Market

9.1. China Follicle Stimulating Hormone Market Overview

9.2. China Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Follicle Stimulating Hormone Market

10.1. India Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Follicle Stimulating Hormone Market

11.1. Japan Follicle Stimulating Hormone Market Overview

11.2. Japan Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Follicle Stimulating Hormone Market

12.1. Australia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Follicle Stimulating Hormone Market

13.1. Indonesia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Follicle Stimulating Hormone Market

14.1. South Korea Follicle Stimulating Hormone Market Overview

14.2. South Korea Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Follicle Stimulating Hormone Market

15.1. Western Europe Follicle Stimulating Hormone Market Overview

15.2. Western Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Follicle Stimulating Hormone Market

16.1. UK Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Follicle Stimulating Hormone Market

17.1. Germany Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Follicle Stimulating Hormone Market

18.1. France Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Follicle Stimulating Hormone Market

19.1. Italy Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Follicle Stimulating Hormone Market

20.1. Spain Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Follicle Stimulating Hormone Market

21.1. Eastern Europe Follicle Stimulating Hormone Market Overview

21.2. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Follicle Stimulating Hormone Market

22.1. Russia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Follicle Stimulating Hormone Market

23.1. North America Follicle Stimulating Hormone Market Overview

23.2. North America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Follicle Stimulating Hormone Market

24.1. USA Follicle Stimulating Hormone Market Overview

24.2. USA Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Follicle Stimulating Hormone Market

25.1. Canada Follicle Stimulating Hormone Market Overview

25.2. Canada Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Follicle Stimulating Hormone Market

26.1. South America Follicle Stimulating Hormone Market Overview

26.2. South America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Follicle Stimulating Hormone Market

27.1. Brazil Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Follicle Stimulating Hormone Market

28.1. Middle East Follicle Stimulating Hormone Market Overview

28.2. Middle East Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Follicle Stimulating Hormone Market

29.1. Africa Follicle Stimulating Hormone Market Overview

29.2. Africa Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Follicle Stimulating Hormone Market Competitive Landscape And Company Profiles

30.1. Follicle Stimulating Hormone Market Competitive Landscape

30.2. Follicle Stimulating Hormone Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Follicle Stimulating Hormone Market Other Major And Innovative Companies

31.1. Merck KGaA

31.2. Teva Pharmaceutical Industries Ltd.

31.3. Sun Pharmaceutical Industries Ltd.

31.4. Intas Pharmaceuticals Ltd.

31.5. Cipla Ltd.

31.6. Ferring Pharmaceuticals Inc.

31.7. Lupin Limited

31.8. Zydus Lifesciences Limited

31.9. Livzon Pharmaceutical Group Inc.

31.10. Emcure Pharmaceuticals Ltd.

31.11. LG Chem's life sciences

31.12. IBSA Group

31.13. Bharat Serums and Vaccines Limited

31.14. Anhui Anke Biotechnology Group Co. Ltd.

31.15. Taj Pharmaceuticals Ltd.

32. Global Follicle Stimulating Hormone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Follicle Stimulating Hormone Market

34. Recent Developments In The Follicle Stimulating Hormone Market

35. Follicle Stimulating Hormone Market High Potential Countries, Segments and Strategies

35.1 Follicle Stimulating Hormone Market In 2029 - Countries Offering Most New Opportunities

35.2 Follicle Stimulating Hormone Market In 2029 - Segments Offering Most New Opportunities

35.3 Follicle Stimulating Hormone Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Recombinant FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Urinary FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: Novartis AG Financial Performance
  • Table 78: Abbott Laboratories Financial Performance
  • Table 79: Sanofi S.A. Financial Performance
  • Table 80: Boehringer Ingelheim GmbH Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Recombinant FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Follicle Stimulating Hormone Market, Sub-Segmentation Of Urinary FSH, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: Novartis AG Financial Performance
  • Figure 78: Abbott Laboratories Financial Performance
  • Figure 79: Sanofi S.A. Financial Performance
  • Figure 80: Boehringer Ingelheim GmbH Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Read More About Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

Read More About Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Read More About $8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

Read More About Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Follicle Stimulating Hormone Global Market Report 2025 – By Type (Recombinant FSH, Urinary FSH), By Application (Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications), By End-Users (Infertili...

View Report

Hormone Therapy Global Market Report 2025 – By Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), By Route of Administration (Oral, Parenteral, Othe...

View Report

Human Growth Hormone Global Market Report 2025 – By Product (Liquid, Powder), By Brand (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Others Brands), By Route Of Administration (Oral, Intravenous, Intr...

View Report

Bioidentical Hormones Global Market Report 2025 – By Type (Estrogen, Progesterone, Testosterone, Other Types), By Product Type (Tablet And Capsule, Cream And Gel, Patch And Implant, Injectable, Other Product Types), By D...

View Report

Gonadotropin-Releasing Hormone (GnRH) Agonist Global Market Report 2025 – By Type (Leuprorelin, Goserelin, Taltirelin, Histrelin, Other Types), By Formulation (Injectable, Implants, Oral, Nasal Sprays), By Distribution C...

View Report

Synthetic Hormones Global Market Report 2025 – By Product Type (Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types), By Route of Administration (Oral, Nasal, Topical, Intravenous), By Applicat...

View Report

Ovulation Inducing Drugs Global Market Report 2025 – By Drug Class (Hormones, Therapeutics Drugs), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By End-User (Hospital, Homecare, Specialty...

View Report

Follicular Lymphoma Treatment Global Market Report 2025 – By Treatment (Monoclonal Antibodies, Targeted Therapy, Chemotherapy, Radiation Therapy, Stem Cell Transplant, Alkylating Agents, Nucleoside Analogues, Anthracycli...

View Report

Frequently Asked Questions

Follicle-stimulating hormone is a hormone that the pituitary gland secretes and is involved in sexual maturation and reproduction. It has an impact on how well the testicles and ovaries work. Follicle-stimulating hormone assists in regulating both the ovaries' egg production and the menstrual cycle. For further insights on this market, request a sample here

The market major growth driver - The Role Of Follicle-Stimulating Hormone In Addressing The Growing Prevalence Of Infertility. For further insights on this market, request a sample here

The follicle stimulating hormone market size has grown steadily in recent years. It will grow from $2.03 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to increased prevalence of hormonal disorders, growing demand for fertility treatment, expansion of FSH indications, market entry of new FSH products, growing demand for safe and effective contraceptive options The follicle stimulating hormone market size is expected to see strong growth in the next few years. It will grow to " $2.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to widening therapeutic applications, rising demand for combination therapy, growing need for effective contraceptive options, aging population and related healthcare needs, market expansion in key regions. Major trends in the forecast period include advanced biosimilar FSH products, regulatory approvals and market access, technological advancements in FSH production and delivery, growing need for effective contraceptive options. For further insights on this market, request a sample here

The follicle stimulating hormone market covered in this report is segmented –
1) By Type: Recombinant FSH, Urinary FSH
2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications
3) By End-Users: Infertility Center, Hospitals, Other End-Users Subsegments:
1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations
2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones For further insights on this market, request a sample here

North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Follicle Stimulating Hormone Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon